Mega menu

Home
Product regulation
Product regulation

Understand your obligations and access industry Guidance and other information about the products we regulate.
Safety and shortages
Safety and shortages

Access information about product recalls, shortages and other alerts, and learn how we manage safety.
Resources and guidance
Resources and guidance

Get information to help you understand our work, regulations and industry obligations.
Business services
Business services

Access our systems to submit applications, manage forms, make payments and communicate securely.

Cipla Australia Pty Ltd

Regulatory activities for this sponsor.

- LinkedIn
- (Twitter)
- Facebook
- Email

Loading...

Type

(-) Cancellation by sponsor (239)
ARTG (460)
Cancellation or suspension (79)
Prescription medicine registration (45)
Cancellation for failure to pay annual charge (17)
Australian public assessment report (AusPar) (5)
Prescription medicine decision summary (4)
Prescription medicine evaluation (1)

Date

2025 (44)
2024 (35)
2023 (42)
2022 (22)
2021 (12)
2020 (17)
2018 (26)
2017 (28)
2016 (5)
2015 (8)

Search

Filters applied:

Cancellation by sponsor

Clear all

Sponsor content

239 result(s) found, displaying 161 to 170

PRICELINE LORATADINE loratadine 10mg tablet blister pack Cancelled under Section 30(1)(c) of the Act

24 June 2020

Cancellation by sponsor

Requested by Cipla Australia Pty Ltd
PHARMACY HEALTH LORATADINE loratadine 10mg tablet blister pack Cancelled under Section 30(1)(c) of the Act

24 June 2020

Cancellation by sponsor

Requested by Cipla Australia Pty Ltd
PHARMACY HEALTH THROAT NUMBING LOZENGES blister pack Cancelled under Section 30(1)(c) of the Act

24 June 2020

Cancellation by sponsor

Requested by Cipla Australia Pty Ltd
PRICELINE PHARMACY THROAT NUMBING LOZENGES blister pack Cancelled under Section 30(1)(c) of the Act

24 June 2020

Cancellation by sponsor

Requested by Cipla Australia Pty Ltd
Suspended from ARTG - PHARMACY HEALTH REFLUX RELIEF EXTRA STRENGTH ranitidine 300mg (as hydrochloride) capsule-shaped tablet blister strip pack Cancelled under Section 30(1)(c) of the Act

24 June 2020

Cancellation by sponsor

Requested by Cipla Australia Pty Ltd
PHARMACY HEALTH FLUCONAZOLE 150mg capsule blister pack Cancelled under Section 30(1)(c) of the Act

24 June 2020

Cancellation by sponsor

Requested by Cipla Australia Pty Ltd
PRICELINE PHARMACY FLUCONAZOLE 150mg capsule blister pack Cancelled under Section 30(1)(c) of the Act

24 June 2020

Cancellation by sponsor

Requested by Cipla Australia Pty Ltd
PHARMACY HEALTH IBUPROFEN + CODEINE film-coated tablet blister pack Cancelled under Section 30(1)(c) of the Act

24 June 2020

Cancellation by sponsor

Requested by Cipla Australia Pty Ltd
PRICELINE PHARMACY IBUPROFEN + CODEINE film-coated tablet blister pack Cancelled under Section 30(1)(c) of the Act

24 June 2020

Cancellation by sponsor

Requested by Cipla Australia Pty Ltd
APO-METFORMIN 500 metformin hydrochloride 500mg tablet blister pack Cancelled under Section 30(1)(c) of the Act

5 June 2020

Cancellation by sponsor

Requested by Cipla Australia Pty Ltd

Pages

First page
Previous page
…
Page 13
Page 14
Page 15
Page 16
Current page 17
Page 18
Page 19
Page 20
Page 21
…
Next page
Last page

Using our website

Accessibility
Privacy
Security
Disclaimer
Copyright
Freedom of information
Acronyms and glossary terms

Quick links

Search our databases
Report a problem or side effect
TGA Business Services
Special Access Scheme
Authorised Prescriber
Office of Drug Control
State and territory contacts

Connect with us

Email subscriptions
Contact us
Facebook
(formerly Twitter)
Youtube
Instagram
LinkedIn

Help us improve

We are always looking for ways to improve our website.

Provide feedback

The Department of Health, Disability and Ageing acknowledges First Nations peoples as the Traditional Owners of Country throughout Australia, and their continuing connection to land, sea and community. We pay our respects to them and their cultures, and to all Elders both past and present.